Integrative analysis of multi-platform reverse-phase protein array data for the pharmacodynamic assessment of response to targeted therapies
Abstract Reverse-phase protein array (RPPA) technology uses panels of high-specificity antibodies to measure proteins and protein post-translational modifications in cells and tissues. The approach offers sensitive and precise quantification of large numbers of samples and has thus found application...
Guardado en:
Autores principales: | Adam Byron, Stephan Bernhardt, Bérèngere Ouine, Aurélie Cartier, Kenneth G. Macleod, Neil O. Carragher, Vonick Sibut, Ulrike Korf, Bryan Serrels, Leanne de Koning |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/07e3b471ccaf448185223b213fb7f35a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
NormaCurve: a SuperCurve-based method that simultaneously quantifies and normalizes reverse phase protein array data.
por: Sylvie Troncale, et al.
Publicado: (2012) -
Developing an environmental research platform in the Karoo at the Square Kilometre Array
por: Helga van der Merwe, et al.
Publicado: (2021) -
Proteasome Inhibitors and Their Pharmacokinetics, Pharmacodynamics, and Metabolism
por: Jinhai Wang, et al.
Publicado: (2021) -
The Overview on the Pharmacokinetic and Pharmacodynamic Interactions of Triazoles
por: Andrzej Czyrski, et al.
Publicado: (2021) -
Transportan 10 improves the pharmacokinetics and pharmacodynamics of vancomycin
por: Jarosław Ruczyński, et al.
Publicado: (2019)